Workflow
Investor Place
icon
Search documents
If You Can Only Buy One Meme Stock in July, It Better Be One of These 3 Names
Investor Place· 2024-07-19 13:17
The S&P 500 has been making new all-time highs on seemingly a weekly basis. And while recent price action in the market has been relatively weak, optimism appears to remain plentiful. Various meme stocks have ridden this sentiment higher during certain bouts of euphoria this year. Yet, many of the top names in the more speculative corners of the market are down considerably from this year’s peak.The question is whether meme stocks as a whole can regain their luster, or if a select few will see the majority ...
Intel Stock Pops After Trump Sinks TSM. What's Going On?
Investor Place· 2024-07-17 21:10
Geopolitical tensions pushed many tech stocks down today — specifically companies in the chipmaking space. For one, former President Donald Trump’s recent comments about Taiwan have created problems for Taiwan Semiconductor (NYSE:TSM). Meanwhile, industry leaders such as Nvidia (NASDAQ:NVDA) are down on general market volatility as President Joe Biden considers further crackdowns on China’s semiconductor manufacturing industry.Amid all this chaos, however, Intel (NASDAQ:INTC) has managed to remain in the gr ...
Why Is GlobalFoundries (GFS) Stock Up Nearly 10% Today?
Investor Place· 2024-07-17 18:13
Core Viewpoint - GlobalFoundries (NASDAQ:GFS) experienced a significant stock increase of approximately 10% due to comments from former President Donald Trump, suggesting that a shift towards isolationist policies may enhance domestic chip production and benefit GFS stock [1][5]. Company Overview - GlobalFoundries, based in Malta, New York, manufactures a variety of semiconductor devices, including microprocessors and power management units. A potential shift in U.S. semiconductor policy aimed at supporting domestic businesses could lead to increased market share for GFS [2]. Geopolitical Context - Trump's remarks indicated that Taiwan has taken a substantial portion of the U.S. chip business, which has geopolitical implications, especially concerning U.S.-China relations over Taiwan [3]. Taiwan is noted to produce over 90% of advanced chips, highlighting its critical role in the semiconductor supply chain [4]. Domestic Policy Impact - The disruptions during the Covid-19 pandemic have intensified the focus on diversifying global semiconductor supply chains. A conservative administration prioritizing domestic chip production could positively impact GFS stock [5]. The Biden administration has also initiated programs to support the U.S. semiconductor industry, with GlobalFoundries receiving awards under the Chips Act [6]. Financial Performance - GFS stock has shown lackluster performance over the past five years, with a total gain of about 20%. Analysts project a revenue decline for the current fiscal year, estimating it to reach $6.72 billion, which represents a 9.1% decrease from the previous year's revenue of $7.39 billion [7]. Even the optimistic revenue estimate of $7.17 billion falls short of expectations [8].
7 Dividend Aristocrats Offering High-Yield Returns
Investor Place· 2024-07-17 10:26
Core Insights - The article focuses on seven prominent companies recognized as Dividend Aristocrats, highlighting their potential returns, income reliability, and sustainability in financial markets [1][2]. Company Summaries Amcor (AMCR) - Amcor leads in packaging solutions with a forward dividend yield of 4.9% and has shown a 1% annual increase in adjusted EPS to $0.178 in Q3 fiscal 2024 [3][4]. - The company reported an adjusted EBIT of $397 million, a 4% increase on a comparable constant currency basis, indicating effective cost management [4]. - Amcor's adjusted free cash flow (FCF) is projected between $850 million and $950 million for fiscal 2024, with a year-to-date increase in FCF by $100 million [4]. Realty Income (O) - Realty Income is a REIT with a forward dividend yield of 5.61%, investing $598 million across retail, industrial, and data centers in Q1 2024 [6][7]. - Over half of the investment volume, $323 million, was allocated in Europe and the U.K. at an 8.2% initial weighted average cash yield [6]. - The portfolio includes over 1,500 clients across multiple countries, with no individual client exceeding 1% of total portfolio annualized rent, mitigating tenant default risk [7]. AT&T (T) - AT&T, a telecommunications giant, offers a forward dividend yield of 5.91% and added 349,000 postpaid phone net subscribers in Q1 2024, totaling 71.6 million [8][9]. - The fiber segment has expanded significantly, passing 2.4 million new locations, increasing the total to over 27 million [9]. - The consumer base for AT&T fiber grew by about 1.1 million to nearly 8.6 million customers, indicating strong subscriber growth [9]. Chevron (CVX) - Chevron, the largest U.S.-integrated energy company, has a forward dividend yield of 4.1% and reported adjusted earnings exceeding $5 billion in Q1 2024 [10][11]. - The company achieved a 35% increase in U.S. output, significantly driven by organic expansion in the Permian Basin [11]. - Chevron returned over $5 billion in cash during Q1 2024, demonstrating effective earnings allocation [12]. ExxonMobil (XOM) - ExxonMobil, another major U.S.-integrated energy company, has a forward dividend yield of 3.3% and generated $8.2 billion in profits in Q1 2024 [13][14]. - The company plans to invest between $23 and $25 billion by 2024, aiming for increased cash flow and profitability [14]. - ExxonMobil's net debt-to-capital ratio has decreased to 3%, the lowest in over 10 years, and it paid out $6.8 billion in dividends [14]. Altria (MO) - Altria, a leading tobacco company, offers an 8.2% forward dividend yield and reported adjusted operating companies' income exceeding $2.4 billion [15][16]. - Marlboro holds a 42% retail share in the cigarette market, with a 0.7 percentage point increase in the premium market [16]. - The company has expanded NJOY's distribution to over 80,000 locations, with plans to reach 100,000 by year-end [16]. T. Rowe Price (TROW) - T. Rowe Price, offering mutual funds and investment services, generated $1.54 trillion in assets under management (AUM) as of Q1 2024, a 12% rise from the previous year [17][18]. - The firm holds $676 billion, or 65%, of retirement assets in U.S.-defined contribution plans, showcasing its strong market position [18]. - T. Rowe Price's stock delivers a forward yield of 4.1%, supported by high AUM growth [18].
Buy Alert: 3 Quality Stocks to Snag Near 52-Week Lows
Investor Place· 2024-07-15 10:00
Group 1: Market Overview - The article discusses the strategy of investing in equities that have suffered significant losses, emphasizing the importance of underlying fundamentals rather than just percentage losses [1][2] - It highlights the potential for stocks near 52-week lows to present investment opportunities, provided there is a legitimate reason for a potential rebound [2][3] Group 2: Dynatrace (DT) - Dynatrace operates in the application software industry, providing a security platform for multi-cloud environments, including application and microservice monitoring [4] - The company has experienced a 19% decline over the past year, yet it has consistently beaten earnings expectations with an average earnings per share of 30 cents against a consensus of 26 cents [5] - Currently, Dynatrace shares are trading at 9.18 times trailing-year sales, which is lower than the average of 11.59 times, with projected sales growth of 15.7% to $1.65 billion by year-end [6] Group 3: SoundThinking (SSTI) - SoundThinking, formerly known as ShotSpotter, provides a gunshot detection system, which has become relevant due to increasing gun violence [7] - The company faces controversy regarding the effectiveness of its technology and sociological implications, but potential law-and-order policies could benefit its stock [8] - SoundThinking shares are currently trading at 1.59 times sales, down from 3.54 times, with projected revenue growth of 13.3% to over $105 million in fiscal 2024 [9] Group 4: Clean Energy Fuels (CLNE) - Clean Energy Fuels operates in the oil and gas refining and marketing industry, focusing on providing natural gas as an alternative fuel for vehicle fleets [10] - The company is not consistently profitable but is considered potentially undervalued, with shares trading at 1.37 times sales compared to nearly 2 times in the past year [11] - Analysts expect revenue growth of 9.5% to $470.13 million in the following year, with a high-side estimate of $526.6 million [11]
FCEL Stock Alert: FuelCell Energy Pops on Korean Market Update
Investor Place· 2024-07-11 17:01
Group 1 - FuelCell Energy is experiencing positive momentum in the Korean market following a successful event on June 28, which focused on accelerating Korea's energy transition with advanced fuel cell solutions [1] - The company's president and CEO, Jason Few, expressed satisfaction with the interest shown by the Korean energy industry and indicated plans for further market growth after 20 years of supplying carbonate fuel cells in the Asia region [1] Group 2 - Following the positive reception of the event, FuelCell Energy's stock (FCEL) saw a trading increase, with over 49.6 million shares changing hands, surpassing its daily average of approximately 48.3 million shares [2] - As of Thursday afternoon, FCEL stock rose by 6.4%, although it has declined by 58.6% since the beginning of the year [2]
Why Is Volcon (VLCN) Stock Up 85% Today?
Investor Place· 2024-07-11 12:05
Group 1 - UBS Group AG has been actively trading shares of Volcon (NASDAQ: VLCN), with transactions occurring from July 5 to July 8 [1][5] - UBS purchased 108 shares of VLCN stock for a total of $488.82, with prices ranging from $4.3885 to $4.53 per share [2] - Following the trades, UBS's indirect holdings in VLCN decreased from 26,131 shares to 24,973 shares [5] Group 2 - The trading activity led to significant interest in VLCN stock, resulting in over 6 million shares traded on Thursday, compared to the average daily volume of approximately 1.1 million shares [6] - As of Thursday morning, VLCN stock has increased by 84.7% [7]
Rep. Josh Gottheimer Is Buying Up Nvidia (NVDA) Stock
Investor Place· 2024-07-10 19:39
Group 1 - New Jersey Rep. Josh Gottheimer purchased between $1,001 and $15,000 worth of Nvidia (NVDA) stock on June 28, joining other politicians like Nancy Pelosi who recently invested in NVDA [1] - Gottheimer also bought shares of Apple, Broadcom, and Microsoft on the same day while selling stocks in John Deere, Lowe's, and Marriott [1] - Gottheimer has made 620 trades in 2023, ranking fourth among Congressional investors, and has an estimated net worth of about $48.42 million [2] Group 2 - Nvidia's stock has increased by 178% this year, surpassing major companies like Apple and Microsoft in market capitalization [3] - Analysts speculate that Nvidia's stock may continue to rise, with predictions that its value could double again by the end of the year [3] - Investors are anticipating Nvidia's upcoming August earnings call for insights into the sustainability of its stock rally [3]
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Investor Place· 2024-07-08 20:45
Group 1: Healthcare Sector Outlook - The outlook for many healthcare stocks is positive, partly due to large investors avoiding the sector, believing it will yield poor returns as long as interest rates remain high [1] Group 2: Walgreens Boots Alliance (WBA) - Walgreens is facing tough competition from large retail chains like Walmart and Target, and increased use of direct mail prescription services has negatively impacted its earnings, which fell to 63 cents per share from 99 cents year-over-year [3] - Analysts predict Walgreens' earnings per share will decline to $2.79 in 2025 from $3.98 in 2023 [4] - The company has significant challenges, including high settlements related to the opioid crisis, resulting in a debt of $33.66 billion and only $711 million in cash as of the end of Q1 [10] - Increased shoplifting and inflation have further hurt Walgreens' financial results, making consumers less willing to pay high prices compared to competitors [19] Group 3: Cassava Sciences (SAVA) - Cassava's only major drug candidate, simufilam, is under scrutiny after Professor Hoau-Yan Wang was indicted for allegedly falsifying data, which could jeopardize the drug's Phase 3 trials [5][11] - If the FDA finds that Cassava knowingly submitted false data, it could lead to severe consequences for the company and a significant drop in its stock price [6][11] - Cassava has been accused of manipulating clinical trial results, raising concerns about the drug's efficacy [12][22] Group 4: Moderna (MRNA) - Moderna's revenue from its Covid-19 vaccine dropped significantly by two-thirds to $6.7 billion last year, as public concern about the virus decreased [14] - Analysts expect Moderna's revenue to decline to $3.85 billion this year from $6.85 billion in 2023 [15] - Moderna's RSV vaccine efficacy is reported at 50% after 18 months, which is less impressive compared to GSK's vaccine that was approved earlier [24]
B. Riley Just Raised Its Price Target on Cinemark (CNK) Stock
Investor Place· 2024-07-08 17:37
Core Viewpoint - The movie theater industry is currently facing challenges, but Cinemark Holdings (NYSE:CNK) is experiencing a positive shift in Wall Street sentiment, reflected in stock upgrades and increased price targets [1][2]. Company Performance - Analyst Eric Wold of B. Reilly Financial raised the price target for CNK stock from $16 to $27 and upgraded the rating from "neutral" to "buy," contributing to a rise in shares [2]. - Cinemark reported a net income of $25 million and adjusted EBITDA of $71 million, with a healthy margin of 12.2%. The company ended the quarter with $789 million in cash and plans to open 36 new screens over the next two years [7]. - Over the past six months, CNK stock has risen approximately 60%, outperforming its main competitor, AMC Entertainment, which has shown minimal growth during the same period [8]. Market Sentiment - There is growing optimism among analysts regarding Cinemark's growth prospects, with six out of seven surveyed analysts rating it as a buy, leading to a moderate buy consensus [9]. - InvestorPlace contributor Stavros Tousios highlighted Cinemark as a potential meme stock, noting its strong financials despite the industry's struggles [3][4].